Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

NCT05498181 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis

Interventions

DRUG: Sacubitril-valsartan
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]